Dr. Khan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
210 E 64th St
Fl 3
New York, NY 10065Phone+1 212-434-4460Fax+1 212-434-4489
Education & Training
MedStar Health/Georgetown University HospitalResidency, Internal Medicine, 2014 - 2017
NYIT College Of Osteopathic MedicineClass of 2014
Certifications & Licensure
FL State License 2022 - Present
NY State License 2018 - 2025
VA State License 2014 - 2018
DC State License 2014 - 2017- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions Start of enrollment: 2019 Jun 28
Roles: Contact
- Testing the Safety and Effectiveness of Combining Two Drugs, PLX2853 and Trametinib in the Treatment of Advanced Uveal Melanoma Start of enrollment: 2023 Jan 13
Roles: Contact
Publications & Presentations
PubMed
- 8 citationsAdjuvant crizotinib in high-risk uveal melanoma following definitive therapy.Shaheer Khan, Jose Lutzky, Alexander N Shoushtari, Joanne Jeter, Brian Marr
Frontiers in Oncology. 2022-01-01 - 11 citationsNovel Approaches to the Systemic Management of Uveal MelanomaShaheer Khan, Richard D. Carvajal
Current Oncology Reports. 2020-07-28 - 73 citationsDissecting the treatment-naive ecosystem of human melanoma brain metastasis.Jana Biermann, Johannes C Melms, Amit Dipak Amin, Yiping Wang, Lindsay A Caprio
Cell. 2022-07-07
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
